Our DC attends the ESGCT Annual Meeting

Our DC Javier Olmos, recruited at SCINUS, presented his research at the 32nd Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), held in Seville, Spain from October 7-10, 2025. His poster focused on the development of a GMP-compliant closed manufacturing protocol for HEK293 cells using the Osilaris bioreactor from Scinus Cell Expansion B.V.

"It was an incredible experience to share my work with leading scientists and innovators," said Javier. "The feedback I received will be invaluable as I move forward with my project."

The ESGCT Congress is a key event for professionals in gene therapy, cell therapy, and genetic vaccines, fostering collaboration and knowledge exchange across Europe. Javier expressed his gratitude to his supervisors, colleagues, and the ESGCT organizers for making the event such a rewarding experience.

Javier expressed his gratitude to his supervisors, colleagues, and the ESGCT organizers for their support in making the event so rewarding. His participation highlights the ongoing efforts of the InnoCAR-T project to advance CAR-T cell therapy and contribute to the next generation of breakthroughs in the field.